Core Focus

This commentary addresses the environmental injustice of beauty product-related chemical exposures, highlighting that women of color face disproportionate toxic chemical exposure from these products—independent of socioeconomic status—and linking this disparity to reproductive and lifelong health inequities. It also explores the social drivers of unequal product use and provides actionable recommendations for healthcare providers, policymakers, and researchers to advance environmental justice and protect women’s reproductive health. Data and arguments align with calls to action from ACOG and FIGO, which emphasize addressing toxic environmental exposures and their disparate impacts on vulnerable populations.

Key Toxic Exposures & Racial/Ethnic Disparities

Beauty products contain unregulated/poorly disclosed reproductive and developmental toxicants (phthalates, heavy metals, parabens, formaldehyde, mercury, talc, etc.), with even low-level exposures during critical developmental stages (e.g., pregnancy) linked to fertility issues, neurodevelopmental harm, cancer, and endocrine disruption. Racial/ethnic disparities in exposure and product use are well-documented, with three key product categories driving inequities:

1. Skin-lightening creams: Used disproportionately by darker-skinned women globally; contain mercury (exceeding FDA limits in unregulated products) leading to mercury poisoning, kidney/central nervous system damage. Linked to colorism and global white beauty norms.

2. Hair relaxers/straighteners: Primary use by Black women (often starting in childhood); contain parabens and estrogenic placenta, associated with premature puberty, earlier menarche, uterine fibroids, and elevated premenopausal breast cancer risk. Driven by societal pressure for "straight/good hair" and workplace discrimination against natural Black hairstyles.

3. Feminine hygiene/fragranced products: Black women are more likely to use vaginal douches and genital talc powder; douching causes higher diethyl phthalate (DEP) exposure, while talc use increases ovarian cancer risk (24% higher overall, greater for Black women). Driven by historical odor discrimination and targeted marketing of odor-masking products.

Social & Structural Drivers of Disparities

1. Racialized beauty norms: Mainstream ideals of whiteness (light skin, straight hair) and colorism create internalized racism, body shame, and pressure to use beauty products to conform.

2. Targeted advertising: The $400 billion global beauty industry markets multicultural products disproportionately to women of color (Black consumers buy 9x more ethnic hair products; Asian Americans spend 70% more on skincare), mirroring harmful targeted marketing of tobacco products to marginalized groups.

3. Cumulative environmental risk: Women of color face overlapping exposures—beauty product toxins plus place-based pollution (e.g., industrial waste)—and the beauty industry’s frontline workers (predominantly women of color/immigrants) face additional occupational chemical hazards with inadequate workplace safety standards.

4. Weak industry regulation: Beauty products have limited and inconsistent ingredient disclosure; most lack adequate health and safety testing, leaving consumers unaware of toxic components.

Critical Observations

• Racial/ethnic differences in beauty product-related chemical levels (e.g., phthalates, parabens) persist after accounting for socioeconomic status, confirming race/structural factors (not income) as core drivers.

• Beauty product use is an understudied source of environmental exposure, and its impacts are often overlooked in cumulative environmental health assessments (which focus on place-based pollution).

• Disparate product use is a form of structural discrimination becoming biologically embedded, directly shaping reproductive health inequities across the life course.

Recommendations for Action

1. Healthcare providers (ObGyns): Be prepared to counsel patients on beauty product toxic risks, recognize demographic disparities in exposure, and use scientific consensus statements to guide patient education (no formal clinical guidelines currently exist).

2. Policymakers & professional societies: Advocate for stricter beauty product regulation—including mandatory ingredient testing, full disclosure of toxic chemicals, and improved workplace safety for beauty industry workers—to advance environmental justice.

3. Researchers: Integrate beauty product use into exposome research (the totality of lifelong environmental exposures); study the joint effects of chemical exposure and psychosocial stress on reproductive health; and address data gaps on racial/ethnic disparities in product use and health outcomes.

4. Public health: Center the environmental injustice of beauty framework in research and interventions, which accounts for social drivers of product use and cumulative environmental impacts on marginalized women.

Conclusion

Beauty product-related chemical exposures are a critical, underrecognized source of reproductive health disparities rooted in environmental injustice. Addressing these inequities requires a multi-pronged approach: challenging racialized beauty norms, strengthening industry regulation, equipping healthcare providers to support vulnerable patients, and centering race/structural factors in environmental and reproductive health research. This work is essential to fulfilling ACOG and FIGO’s mandate to secure environmental justice and eliminate health disparities for all women.